Bumper Offer - Urjas oil Just @ Rs. 1
Gabajet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Neuropathic Pain, Epilepsy. Secondary and off-label uses of Gabajet have also been mentioned below.
The right dosage of Gabajet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Gabajet have been listed ahead. Such side effects of Gabajet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Gabajet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Gabajet's effects on the liver, heart and kidney, if any, have been listed below.
Gabajet is contraindicated in people with pre-existing medical conditions like Kidney Disease as it can result in adverse effects. The section on Gabajet contraindications lists all such conditions.
Additionally, Gabajet may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Gabajet is considered not safe while driving, and is not addictive.
Gabajet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Gabajet is used -
Moderate
Mild
Is the use of Gabajet safe for pregnant women?
Gabajet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Gabajet right away. Take your doctor's advice before taking it again.
Is the use of Gabajet safe during breastfeeding?
Gabajet can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Gabajet on the Kidneys?
Gabajet rarely affects the kidneys.
What is the effect of Gabajet on the Liver?
Gabajet does not damage the liver.
What is the effect of Gabajet on the Heart?
Using Gabajet does not have any harmful effects on the heart.
Gabajet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Gabajet unless your doctor advises you to do so -
Is this Gabajet habit forming or addictive?
Yes, Gabajet can get addictive. Consume it only after doctor's advise.
Is it safe to drive or operate heavy machinery when consuming?
After taking Gabajet, you should not drive or work on any heavy machine, as Gabajet can make you drowsy.
Is it safe?
Yes, Gabajet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, in many cases, taking Gabajet can help with mental disorders.
Interaction between Food and Gabajet
Taking Gabajet with food does not cause any problems.
Interaction between Alcohol and Gabajet
Taking Gabajet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
